The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...

The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.

Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without ...

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...

The agreement has been designed to offer a turnkey service to companies seeking faster time to market.

The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.

Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification ...

The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry ...

The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...

Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers ...